Back
Rhythm Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
RYTM
Rhythm Pharmaceuticals
Last Price:
$65.18
Seasonality Move:
15.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.21 | Buy |
| 20-day SMA: | 58.51 | Buy |
| 50-day SMA: | 55.56 | Buy |
| 200-day SMA: | 53.67 | Buy |
| 8-day EMA: | 62.62 | Buy |
| 20-day EMA: | 59.77 | Buy |
| 50-day EMA: | 57.26 | Buy |
| 200-day EMA: | 52.86 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.62 | Buy |
| Relative Strength Index (14 RSI): | 66.01 | Buy |
| Chaikin Money Flow: | 252910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.63 - 62.47) | Buy |
| Bollinger Bands (100): | (52.98 - 60.08) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 65.22 while RYTM 8-day simple moving average is 62.21, which is a Buy signal.
-
The stock price of RYTM is 65.22 while Rhythm Pharmaceuticals 20-day SMA is 58.51, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day simple moving average is 55.56 while RYTM share price is 65.22, making it a Buy technically.
-
RYTM stock price is 65.22 and Rhythm Pharmaceuticals 200-day simple moving average is 53.67, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
65
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a BuyThe current Rhythm Pharmaceuticals [RYTM] share price is $65.22. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
4.1B
Price in USD:
65.22
Share Volume:
364.1K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
68.58
52-Week Low:
35.17
Buy
65
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 65.22 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 65.22 while RYTM 8-day exponential moving average is 62.62, which is a Buy signal.
-
The stock price of RYTM is 65.22 while Rhythm Pharmaceuticals 20-day EMA is 59.77, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 57.26 while RYTM share price is 65.22, making it a Buy technically.
-
RYTM stock price is 65.22 and Rhythm Pharmaceuticals 200-day simple moving average is 52.86, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 2.62, suggesting Rhythm Pharmaceuticals is a Buy
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 66.01, which suggest Rhythm Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (52.63 - 62.47), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (52.98 - 60.08), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.